N. Iwakura, S. Ohtori, S. Orita, M. Yamashita, K. Takahashi et al., Role of Low-Affinity Nerve Growth Factor Receptor Inhibitory Antibody in Reducing Pain Behavior and Calcitonin Gene-Related Peptide Expression in a Rat Model of Wrist Joint Inflammatory Pain, The Journal of Hand Surgery, vol.35, issue.2, pp.267-273, 2010.
DOI : 10.1016/j.jhsa.2009.10.030

N. Lane, T. Schnitzer, C. Birbara, M. Mokhtarani, D. Shelton et al., Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee, New England Journal of Medicine, vol.363, issue.16, pp.1521-1531, 2010.
DOI : 10.1056/NEJMoa0901510

K. Mcnamee, A. Burleigh, L. Gompels, M. Feldmann, S. Allen et al., Treatment of murine osteoarthritis with TrkAd5 reveals a pivotal role for nerve growth factor in non-inflammatory joint pain, Pain, vol.149, issue.2, pp.386-392, 2010.
DOI : 10.1016/j.pain.2010.03.002

M. Brown, F. Murphy, D. Radin, I. Davignon, M. Smith et al., Tanezumab Reduces Osteoarthritic Hip Pain: Results of a Randomized, Double-Blind, Placebo-Controlled Phase III Trial, Arthritis & Rheumatism, vol.168, issue.7, pp.1795-1803, 2013.
DOI : 10.1002/art.37950

M. Hochberg, S. Abramson, D. Hungerford, . Em, E. Vignon et al., Adjudication of reported serious adverse joint events in the Tanezumab clinical development program, Arthritis Rheum, vol.64, p.113, 2012.

M. Seidel, M. Herguijuela, R. Forkert, and U. Otten, Nerve Growth Factor in Rheumatic Diseases, Seminars in Arthritis and Rheumatism, vol.40, issue.2, pp.109-126, 2010.
DOI : 10.1016/j.semarthrit.2009.03.002

L. Aloe, M. Tuveri, and R. Levi-montalcini, Nerve growth factor and distribution of mast cells in the synovium of adult rats, Clin Exp Rheumatol, vol.10, pp.203-204, 1992.
DOI : 10.1142/9789812830319_0033

E. Smelter and M. Hochberg, New treatments for osteoarthritis, Current Opinion in Rheumatology, vol.25, issue.3, pp.310-316, 2013.
DOI : 10.1097/BOR.0b013e32835f69b4

T. Mammoto, R. Seerattan, K. Paulson, C. Leonard, R. Bray et al., Nerve growth factor improves ligament healing, Journal of Orthopaedic Research, vol.41, issue.7, pp.957-964, 2008.
DOI : 10.1002/jor.20615

H. Huang, G. Shank, L. Ma, R. Tallents, and S. Kyrkanides, Nerve growth factor induced after temporomandibular joint inflammation decelerates chondrocyte differentiation, Oral Diseases, vol.151, issue.Suppl 3, pp.604-610, 2013.
DOI : 10.1111/odi.12045

M. Amico-roxas, A. Caruso, M. Leone, R. Scifo, A. Vanella et al., Nerve growth factor inhibits some acute experimental inflammations, Arch Int Pharmacodyn Ther, vol.299, pp.269-285, 1989.

V. Nordell, D. Lewis, S. Bake, and F. Sohrabji, The neurotrophin receptor p75NTR mediates early anti-inflammatory effects of estrogen in the forebrain of young adult rats, BMC Neuroscience, vol.6, issue.1, p.58, 2005.
DOI : 10.1186/1471-2202-6-58

L. Manni, T. Lundeberg, S. Fiorito, S. Bonini, E. Vigneti et al., Nerve growth factor release by human synovial fibroblasts prior to and following exposure to tumor necrosis factor-alpha, interleukin-1 beta and cholecystokinin-8: the possible role of NGF in the inflammatory response, Clin Exp Rheumatol, vol.21, pp.617-624, 2003.

R. Gomez, J. Conde, M. Scotece, J. Gomez-reino, F. Lago et al., What's new in our understanding of the role of adipokines in rheumatic diseases?, Nature Reviews Rheumatology, vol.1732, issue.9, pp.528-536, 2011.
DOI : 10.1038/nrrheum.2011.107

M. Gosset, F. Berenbaum, C. Salvat, A. Sautet, A. Pigenet et al., Crucial role of visfatin/pre???B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: Possible influence on osteoarthritis, Arthritis & Rheumatism, vol.48, issue.5, pp.1399-1409, 2008.
DOI : 10.1002/art.23431

L. Aloe, M. Tuveri, U. Carcassi, and R. Levi-montalcini, Nerve growth factor in the synovial fluid of patients with chronic arthritis, Arthritis & Rheumatism, vol.186, issue.3, pp.351-355, 1992.
DOI : 10.1002/art.1780350315

A. Gigante, C. Bevilacqua, A. Pagnotta, S. Manzotti, A. Toesca et al., Expression of NGF, Trka and p75 in human cartilage, Eur J Histochem, vol.47, pp.339-344, 2003.

O. Grimsholm, Y. Guo, T. Ny, and S. Forsgren, Expression Patterns of Neurotrophins and Neurotrophin Receptors in Articular Chondrocytes and Inflammatory Infiltrates in Knee Joint Arthritis, Cells Tissues Organs, vol.188, issue.3, pp.299-309, 2008.
DOI : 10.1159/000121432

F. Iannone, D. Bari, C. Dell-'accio, F. Covelli, M. Patella et al., Increased expression of nerve growth factor (NGF) and high affinity NGF receptor (p140 TrkA) in human osteoarthritic chondrocytes, Rheumatology, vol.41, issue.12, pp.1413-1418, 2002.
DOI : 10.1093/rheumatology/41.12.1413

W. Friedman, L. Larkfors, C. Ayer-lelievre, T. Ebendal, L. Olson et al., Regulation of ??-nerve growth factor expression by inflammatory mediators in hippocampal cultures, Journal of Neuroscience Research, vol.434, issue.3, pp.374-382, 1990.
DOI : 10.1002/jnr.490270316

L. Manni and L. Aloe, Role of IL-1 b and TNF- a in the regulation of NGF in experimentally induced arthritis in mice, Rheumatology International, vol.18, issue.3, pp.97-102, 1998.
DOI : 10.1007/s002960050065

R. Altman, E. Asch, D. Bloch, G. Bole, D. Borenstein et al., Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee, Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association, pp.1039-1049, 1986.
DOI : 10.1002/art.1780290816

C. Salvat, A. Pigenet, L. Humbert, F. Berenbaum, and S. Thirion, Immature murine articular chondrocytes in primary culture: a new tool for investigating cartilage. Osteoarthritis Cartilage, pp.243-249, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00017735

M. Gosset, F. Berenbaum, A. Levy, A. Pigenet, S. Thirion et al., Prostaglandin E2 synthesis in cartilage explants under compression: mPGES-1 is a mechanosensitive gene, Arthritis Research & Therapy, vol.8, issue.4, p.135, 2006.
DOI : 10.1186/ar2024

W. Chen, J. Bao, J. Feng, P. Hu, Z. Shi et al., Increased serum concentrations of visfatin and its production by different joint tissues in patients with osteoarthritis, Clinical Chemistry and Laboratory Medicine, vol.48, issue.8, pp.1141-1145, 2010.
DOI : 10.1515/CCLM.2010.230

C. Jacques, M. Holzenberger, Z. Mladenovic, C. Salvat, E. Pecchi et al., Proinflammatory Actions of Visfatin/Nicotinamide Phosphoribosyltransferase (Nampt) Involve Regulation of Insulin Signaling Pathway and Nampt Enzymatic Activity, Journal of Biological Chemistry, vol.287, issue.18, pp.15100-15108, 2012.
DOI : 10.1074/jbc.M112.350215

M. Hasmann and I. Schemainda, FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis, Cancer Res, vol.63, pp.7436-7442, 2003.

D. Clemow, W. Steers, and J. Tuttle, Stretch-activated signaling of nerve growth factor secretion in bladder and vascular smooth muscle cells from hypertensive and hyperactive rats, Journal of Cellular Physiology, vol.1, issue.3, pp.289-300, 2000.
DOI : 10.1002/(SICI)1097-4652(200006)183:3<289::AID-JCP1>3.0.CO;2-6

O. Rana, P. Schauerte, D. Hommes, R. Schwinger, J. Schroder et al., Mechanical stretch induces nerve sprouting in rat sympathetic neurocytes, Autonomic Neuroscience, vol.155, issue.1-2, pp.25-32, 2010.
DOI : 10.1016/j.autneu.2010.01.003

R. , R. Ie,-m-e-y-e-rc,-g-e-m-e-i-nc,-k-r-u-t-t-g-e-na, G. Ludwig, A. Schotten, U. Schwinger et al., Regulation of nerve growth factor in the heart: the role of the calcineurin-NFAT pathway, pp.568-578, 2009.

Y. Abe, K. Akeda, H. An, Y. Aoki, R. Pichika et al., Proinflammatory Cytokines Stimulate the Expression of Nerve Growth Factor by Human Intervertebral Disc Cells, Spine, vol.32, issue.6, pp.635-642, 1976.
DOI : 10.1097/01.brs.0000257556.90850.53

D. Purmessur, A. Freemont, and J. Hoyland, Expression and regulation of neurotrophins in the nondegenerate and degenerate human intervertebral disc, Arthritis Research & Therapy, vol.10, issue.4, p.99, 2008.
DOI : 10.1186/ar2487

P. Taishi, L. Churchill, A. De, F. Obal, . Jr et al., Cytokine mRNA induction by interleukin-1?? or tumor necrosis factor ?? in vitro and in vivo, Brain Research, vol.1226, pp.89-98, 2008.
DOI : 10.1016/j.brainres.2008.05.067

J. Lee, J. Song, M. Baek, H. Jung, H. Kang et al., Interleukin-1?? induces angiogenesis and innervation in human intervertebral disc degeneration, Journal of Orthopaedic Research, vol.23, issue.2, pp.265-269, 2011.
DOI : 10.1002/jor.21210

P. Alstergren, M. Ernberg, M. Kvarnstrom, and S. Kopp, Interleukin-1?? in synovial fluid from the arthritic temporomandibular joint and its relation to pain, mobility, and anterior open bite, Journal of Oral and Maxillofacial Surgery, vol.56, issue.9, pp.1059-1065, 1998.
DOI : 10.1016/S0278-2391(98)90256-7

M. Gotoh, K. Hamada, H. Yamakawa, K. Yanagisawa, M. Nakamura et al., Interleukin-1-induced subacromial synovitis and shoulder pain in rotator cuff diseases, Rheumatology, vol.40, issue.9, pp.995-1001, 2001.
DOI : 10.1093/rheumatology/40.9.995

M. Attur, I. Belitskaya-levy, C. Oh, S. Krasnokutsky, J. Greenberg et al., Increased interleukin-1?? gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis, Arthritis & Rheumatism, vol.25, issue.Suppl, pp.1908-1917, 2011.
DOI : 10.1002/art.30360

R. Terkeltaub, J. Sundy, H. Schumacher, F. Murphy, S. Bookbinder et al., The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study, Annals of the Rheumatic Diseases, vol.68, issue.10, pp.1613-1617, 2009.
DOI : 10.1136/ard.2009.108936

I. Kone-paut, H. Lachmann, J. Kuemmerle-deschner, E. Hachulla, K. Leslie et al., Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study, Arthritis Research & Therapy, vol.13, issue.6, p.202, 2011.
DOI : 10.1136/ard.2003.010769

F. Berenbaum and F. Eymard, Osteoarthritis, inflammation and obesity, Current Opinion in Rheumatology, vol.25, issue.1, pp.114-118, 2013.
DOI : 10.1097/BOR.0b013e32835a9414

A. Fukuhara, M. Matsuda, M. Nishizawa, K. Segawa, M. Tanaka et al., Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin, Science, vol.307, issue.5708, pp.426-430, 2005.
DOI : 10.1126/science.1097243

Y. Duan, D. Hao, M. Li, Z. Wu, D. Li et al., Increased synovial fluid visfatin is positively linked to cartilage degradation biomarkers in osteoarthritis, Rheumatology International, vol.65, issue.9, pp.1433-1437, 2012.
DOI : 10.1007/s00296-010-1731-8

P. Cirillo, D. Palma, V. Maresca, F. Pacifico, F. Ziviello et al., The adipokine visfatin induces tissue factor expression in human coronary artery endothelial cells, Thrombosis Research, vol.130, issue.3, pp.403-408, 2012.
DOI : 10.1016/j.thromres.2012.06.007

Y. Fan, S. Meng, Y. Wang, J. Cao, and C. Wang, Visfatin/PBEF/Nampt induces EMMPRIN and MMP-9 production in macrophages via the NAMPT-MAPK (p38, ERK1/2)-NF-kappaB signaling pathway, Int J Mol Med, vol.27, pp.607-615, 2011.

T. Romacho, V. Azcutia, M. Vazquez-bella, N. Matesanz, E. Cercas et al., Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity, Diabetologia, vol.283, issue.11, pp.2455-2463, 2009.
DOI : 10.1007/s00125-009-1509-2

N. Busso, M. Karababa, M. Nobile, A. Rolaz, F. Van-gool et al., Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase/Visfatin Enzymatic Activity Identifies a New Inflammatory Pathway Linked to NAD, PLoS ONE, vol.222, issue.5, p.2267, 2008.
DOI : 10.1371/journal.pone.0002267.t001

L. Evans, A. Williams, A. Hayes, S. Jones, and M. Nowell, Suppression of leukocyte infiltration and cartilage degradation by selective inhibition of pre-B cell colony-enhancing factor/visfatin/nicotinamide phosphoribosyltransferase: Apo866-mediated therapy in human fibroblasts and murine collagen-induced arthrit, Arthritis & Rheumatism, vol.284, issue.7, pp.1866-1877, 2011.
DOI : 10.1002/art.30338

A. Grahnert, A. Grahnert, C. Klein, E. Schilling, J. Wehrhahn et al., Review: NAD + : A modulator of immune functions, Innate Immunity, vol.15, issue.2, pp.212-233, 2010.
DOI : 10.1136/ard.2005.046540

F. Koch-nolte, S. Fischer, F. Haag, and M. Ziegler, -dependent signalling, FEBS Letters, vol.67, issue.11, pp.1651-1656, 2011.
DOI : 10.1016/j.febslet.2011.03.045

URL : https://hal.archives-ouvertes.fr/hal-00016889

E. Chang, Y. Im, E. Kay, J. Kim, J. Lee et al., The role of nerve growth factor in hyperosmolar stress induced apoptosis, Journal of Cellular Physiology, vol.24, issue.1, pp.69-77, 2008.
DOI : 10.1002/jcp.21377

W. Friedman, N. Altiok, B. Fredholm, and H. Persson, Mechanisms of nerve growth factor mRNA regulation by interleukin-1? in hippocampal cultures: Role of second messengers, Journal of Neuroscience Research, vol.20, issue.1, pp.37-46, 1992.
DOI : 10.1002/jnr.490330106

M. Gosset, F. Berenbaum, A. Levy, A. Pigenet, S. Thirion et al., Mechanical stress and prostaglandin E2 synthesis in cartilage, Biorheology, vol.45, pp.301-320, 2008.

F. Berenbaum, C. Jacques, G. Thomas, M. Corvol, G. Bereziat et al., Synergistic Effect of Interleukin-1?? and Tumor Necrosis Factor ?? on PGE2Production by Articular Chondrocytes Does Not Involve PLA2Stimulation, Experimental Cell Research, vol.222, issue.2, pp.379-384, 1996.
DOI : 10.1006/excr.1996.0047

M. Toyomoto, M. Ohta, K. Okumura, H. Yano, K. Matsumoto et al., Prostaglandins are powerful inducers of NGF and BDNF production in mouse astrocyte cultures, FEBS Letters, vol.54, issue.2013, pp.211-215, 2004.
DOI : 10.1016/S0014-5793(04)00246-7

D. Toso, R. , D. Bernardi, M. Brooker, G. Costa et al., Beta adrenergic and prostaglandin receptor activation increases nerve growth factor mRNA content in C6-2B rat astrocytoma cells, J Pharmacol Exp Ther, vol.246, pp.1190-1193, 1988.

J. Chidiac, B. Al-asmar, K. Rifai, S. Jabbur, and N. Saade, Inflammatory mediators released following application of irritants on the rat injured incisors. The effect of treatment with anti-inflammatory drugs, Cytokine, vol.46, issue.2, pp.194-200, 2009.
DOI : 10.1016/j.cyto.2009.01.008

T. Samad, K. Moore, A. Sapirstein, S. Billet, A. Allchorne et al., Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity, Nature, vol.410, issue.6827, pp.471-475, 2001.
DOI : 10.1038/35068566

M. Bullo, M. Peeraully, and P. Trayhurn, Stimulation of NGF expression and secretion in 3T3-L1 adipocytes by prostaglandins PGD2, PGJ2, and ??12-PGJ2, AJP: Endocrinology and Metabolism, vol.289, issue.1, pp.62-67, 2005.
DOI : 10.1152/ajpendo.00008.2005

J. Borglum, S. Pedersen, G. Ailhaud, R. Negrel, and B. Richelsen, Differential expression of prostaglandin receptor mRNAs during adipose cell differentiation, Prostaglandins & Other Lipid Mediators, vol.57, issue.5-6, pp.305-317, 1999.
DOI : 10.1016/S0090-6980(98)00082-3

C. Clark, E. Schwarz, X. Zhang, N. Ziran, H. Drissi et al., Differential regulation of EP receptor isoforms during chondrogenesis and chondrocyte maturation, Biochemical and Biophysical Research Communications, vol.328, issue.3, pp.764-776, 2005.
DOI : 10.1016/j.bbrc.2004.11.074

A. De-brum-fernandes, S. Morisset, G. Bkaily, and C. Patry, Characterization of the PGE2 receptor subtype in bovine chondrocytes in culture, British Journal of Pharmacology, vol.19, issue.7, pp.1597-1604, 1996.
DOI : 10.1111/j.1476-5381.1996.tb15580.x